As the global economy mends, the 2021 growth of Hepatitis Testing Diagnosis will have significant change from previous year. According to our researcher latest study, the global Hepatitis Testing Diagnosis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Hepatitis Testing Diagnosis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Hepatitis Testing Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Hepatitis Testing Diagnosis market, reaching US$ million by the year 2028. As for the Europe Hepatitis Testing Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Hepatitis Testing Diagnosis players cover F. Hoffmann-La Roche, Abbott Laboratories, Siemens Healthineers AG, and Bio-Rad Laboratories, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis Testing Diagnosis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Enzyme-linked Immunosorbent Assay (ELISA)

Rapid Diagnostic Tests (RDT)

Polymerase Chain Reaction (PCR)

Isothermal Nucleic Acid Amplification Technology (INAAT)

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Blood Banks

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

F. Hoffmann-La Roche

Abbott Laboratories

Siemens Healthineers AG

Bio-Rad Laboratories

Danaher Corporation

QIAGEN

BioMerieux SA

DiaSorin S.P.A.

Ortho Clinical Diagnostics

MedMira Inc

Fujirebio

Grifols

Orasure Technologies

GenMark Diagnostics

Vela Diagnostics

Epitope Diagnostics

Trivitron Healthcare

Meril Life Sciences

geneOmbio Technologies

Molbio Diagnostics